[The Effect of the Antioxidant Drug @entity49463 on Magnesium Levels During @entity519 -Reoxygenation Injury in XXXX ].

@entity1025 @entity519 @entity49463 @entity35 @entity1760
OBJECTIVE: The aim of this experimental study was to examine the effect of the antioxidant drug @entity49463 in a @entity35 model of @entity519 -reoxygenation using the previously established protocol. Effects of treatments were evaluated by @entity1760 ( @entity1025 ) levels in blood. METHODS: Non-randomized controlled study was performed. @entity1025 levels were determined in 60 min (groups A and C) and 120 min (groups B and D) after starting the reoxygenation. Groups A and B received no drugs, whereas @entity35 from groups C and D were administered with @entity49463 . RESULTS: 40 @entity35 16-18 weeks old of a mean weight of 2312 g were employed in the study. It is demonstrated that @entity49463 administration did not alter the @entity1025 levels (decrease in @entity1025 concentration was 0.28  2.75%; p=0.917). Reoxygenation non-significantly increased the @entity1025 levels by 4.27  2.66% (p=0.107). Together, the @entity49463 administration and reoxygenation non-significantly increased the @entity1025 levels by 0.36  1.64% (p=0.823). CONCLUSION: @entity49463 administration, alone or in concert with reoxygenation did not significantly affect @entity1025 level in blood after experimental @entity519 in @entity35 .
